CN1150904C - 分子碘的口服给药的药物组合物 - Google Patents

分子碘的口服给药的药物组合物

Info

Publication number
CN1150904C
CN1150904C CNB988097648A CN98809764A CN1150904C CN 1150904 C CN1150904 C CN 1150904C CN B988097648 A CNB988097648 A CN B988097648A CN 98809764 A CN98809764 A CN 98809764A CN 1150904 C CN1150904 C CN 1150904C
Authority
CN
China
Prior art keywords
iodine
iodide
iodate
composition
molecular iodine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB988097648A
Other languages
English (en)
Chinese (zh)
Other versions
CN1272789A (zh
Inventor
Y
Y·段
J·海基
R·帕尼库西
J·凯斯勒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Symbollon Corp
Original Assignee
Symbollon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbollon Corp filed Critical Symbollon Corp
Publication of CN1272789A publication Critical patent/CN1272789A/zh
Application granted granted Critical
Publication of CN1150904C publication Critical patent/CN1150904C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNB988097648A 1997-10-29 1998-10-27 分子碘的口服给药的药物组合物 Expired - Fee Related CN1150904C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/960,149 1997-10-29
US08/960,149 US5885592A (en) 1997-10-29 1997-10-29 Methods and pharmaceutical compositions for oral delivery of molecular iodine

Publications (2)

Publication Number Publication Date
CN1272789A CN1272789A (zh) 2000-11-08
CN1150904C true CN1150904C (zh) 2004-05-26

Family

ID=25502851

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB988097648A Expired - Fee Related CN1150904C (zh) 1997-10-29 1998-10-27 分子碘的口服给药的药物组合物

Country Status (17)

Country Link
US (1) US5885592A (OSRAM)
EP (1) EP1024815B1 (OSRAM)
JP (1) JP4187410B2 (OSRAM)
KR (1) KR100412219B1 (OSRAM)
CN (1) CN1150904C (OSRAM)
AT (1) ATE231725T1 (OSRAM)
AU (1) AU750627B2 (OSRAM)
BR (1) BR9812588A (OSRAM)
CA (1) CA2301503C (OSRAM)
DE (1) DE69811105T2 (OSRAM)
DK (1) DK1024815T3 (OSRAM)
ES (1) ES2191973T3 (OSRAM)
IL (1) IL134778A0 (OSRAM)
NO (1) NO20001673L (OSRAM)
PT (1) PT1024815E (OSRAM)
RU (1) RU2213564C2 (OSRAM)
WO (1) WO1999021567A1 (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106102836A (zh) * 2014-02-10 2016-11-09 弗雷德哈钦森癌症研究中心 心脏病发作和缺血性损伤的卤素治疗

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248335B1 (en) * 1997-10-29 2001-06-19 Symbollon Corporation Stabilized oral pharmaceutical composition containing iodide and iodate and method
EP1044689A4 (en) * 1998-01-06 2002-07-03 Fujisawa Pharmaceutical Co SOLID IODOPHORE BASED PREPARATIONS AND MANUFACTURING METHOD THEREOF
CN1306444A (zh) 1998-06-19 2001-08-01 奥西比奥公司 具有抗感染和避孕性能的医学装置
US6154672A (en) * 1998-06-22 2000-11-28 Pacesetter, Inc. Method and apparatus for improving the probability of success of defibrillation shocks
GB2395901A (en) * 1999-02-26 2004-06-09 Symbollon Corp Stabilised tablets containing iodide and iodate
PT1195178E (pt) * 2000-10-06 2006-10-31 Dmg Italia Srl Preparacao imunotrofica para o tratamento da hipertrofia adenoamigdalar.
RU2201229C1 (ru) * 2002-03-26 2003-03-27 Миронов Владимир Андреевич Способ оздоровления организма
US8501223B2 (en) * 2003-06-20 2013-08-06 Hill's Pet Nutrition, Inc. Methods for dietary management of cats to avoid hyperthyroidism
BRPI0411712B1 (pt) * 2003-06-20 2015-07-07 Hills Pet Nutrition Inc Composição com iodo reduzido embalada para dieta de felinos para restabelecer a função normal da tireóide
EP2666366B1 (en) * 2006-01-26 2015-03-11 Hill's Pet Nutrition, Inc. Methods and compositions for treating feline hyperthyroidism
US20090269416A1 (en) * 2006-05-12 2009-10-29 Hill's Pet Nutrition , Inc. Compositions and Methods For Preventing or Treating Chronic Renal Failure in Felines With Hyperthyroidism
US8303994B2 (en) * 2006-06-22 2012-11-06 Jack Howard Kessler Method for the eradication of pathogens including S. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells
EP2040565B1 (en) * 2006-07-03 2013-01-02 Hill's Pet Nutrition, Inc. Copositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
WO2009087647A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders
MX340005B (es) * 2010-04-23 2016-05-18 Univ Nac Autónoma De México Composicion de yodo molecular de uso humano para la prevencion y tratamiento de patologias prostaticas.
CN103561735B (zh) * 2011-05-16 2016-01-20 S·S·别尕里耶夫 具有抗菌、抗溃疡和免疫调节作用的药物制剂
CN102697804B (zh) * 2012-06-07 2014-02-12 维尔信科技（潍坊）有限公司 一种固态分子碘消毒制剂及其制备方法
US10034899B2 (en) * 2013-11-27 2018-07-31 BioPharmX, Inc. Solid oral dosage form for breast symptoms
CN106163577A (zh) * 2014-03-31 2016-11-23 艾欧泰克国际股份有限公司 未络合的碘的稳定组合物以及使用方法
EA031907B1 (ru) * 2016-03-11 2019-03-29 Тимур Хусаинович Измайлов Шашка иодная дымовая
WO2017185060A1 (en) 2016-04-21 2017-10-26 BioPharmX, Inc. Oral iodine dosage form
MX2019000902A (es) 2016-07-21 2020-09-03 I2Pure Corp Desinfectantes topicos emolientes.
CN106727683A (zh) * 2016-12-23 2017-05-31 刘海涛 一种药物制剂在制备治疗幽门螺杆菌感染性疾病的药物中的应用
TW202203900A (zh) * 2020-03-31 2022-02-01 越南商泰明製藥股份有限公司 用於治療癌症、子宮內膜異位症以及癌症或子宮內膜異位症患者的疼痛之二異丙胺化合物以及碘
EP4196094A4 (en) 2020-08-13 2024-11-13 I2Pure Corp. High molecular iodine concentration compositions, pharmaceutical formulations, preparation and uses
WO2024201560A1 (en) * 2023-03-24 2024-10-03 Me.Link Co., Ltd. Iodine containing colloidal liquid composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540170C3 (de) * 1975-09-10 1979-01-18 Basf Ag, 6700 Ludwigshafen Verwendung von in organischer Lösung hergestelltem Polyvinylpyrrolidon zur Herstellung von stabilen wäßrigen PoIyvinylpyrrolidon-Jod-Lösungen
US4259322A (en) * 1978-03-20 1981-03-31 Helong Lim Method of treatment of tuberculosis
US4187294A (en) * 1978-07-06 1980-02-05 Nihon Nousan Kougyou Co., Ltd. Method for producing eggs containing a high amount of iodinated amino acids
JPS5663919A (en) * 1979-10-29 1981-05-30 Nippon Nousan Kogyo Kk Remedial composition for diabetes
JPS57140723A (en) * 1981-02-25 1982-08-31 Nippon Nousan Kogyo Kk Preventing composition for hyperlipemia due to neutral fat
US4816255A (en) * 1985-07-31 1989-03-28 Ghent William R Treatment of iodine deficiency breast syndrome
US5250304A (en) * 1985-07-31 1993-10-05 Ghent William R Treatment of iodine deficiency diseases
US5171582A (en) * 1985-07-31 1992-12-15 Ghent William R Treatment of iodine deficiency diseases
US5589198A (en) * 1985-07-31 1996-12-31 943038 Ontario, Inc. Treatment of iodine deficiency diseases
US4849237A (en) * 1987-10-30 1989-07-18 Hurst William D Method for sanitizing poultry carcasses in a poultry processing plant utilizing ozonated water
US5629024A (en) * 1994-08-22 1997-05-13 Symbollon Corporation Method of forming an iodine based germicide composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106102836A (zh) * 2014-02-10 2016-11-09 弗雷德哈钦森癌症研究中心 心脏病发作和缺血性损伤的卤素治疗
CN106102836B (zh) * 2014-02-10 2020-02-04 弗雷德哈钦森癌症研究中心 心脏病发作和缺血性损伤的卤素治疗

Also Published As

Publication number Publication date
EP1024815A1 (en) 2000-08-09
ES2191973T3 (es) 2003-09-16
DE69811105D1 (de) 2003-03-06
JP2003510243A (ja) 2003-03-18
JP4187410B2 (ja) 2008-11-26
CN1272789A (zh) 2000-11-08
WO1999021567A1 (en) 1999-05-06
NO20001673L (no) 2000-05-24
DE69811105T2 (de) 2003-11-06
CA2301503C (en) 2005-01-04
IL134778A0 (en) 2001-04-30
AU1122799A (en) 1999-05-17
DK1024815T3 (da) 2003-05-19
EP1024815B1 (en) 2003-01-29
PT1024815E (pt) 2003-06-30
NO20001673D0 (no) 2000-03-31
RU2213564C2 (ru) 2003-10-10
AU750627B2 (en) 2002-07-25
KR100412219B1 (ko) 2003-12-24
US5885592A (en) 1999-03-23
CA2301503A1 (en) 1999-05-06
KR20010030861A (ko) 2001-04-16
ATE231725T1 (de) 2003-02-15
BR9812588A (pt) 2000-07-25

Similar Documents

Publication Publication Date Title
CN1150904C (zh) 分子碘的口服给药的药物组合物
FI77371B (fi) Foerfarande foer framstaellning av en kapsel, som innehaoller ett alkaliskt aemne och acetylsalicylsyra.
US4226849A (en) Sustained release therapeutic compositions
US7381428B2 (en) Stabilized lanthanum carbonate compositions
JP6687963B2 (ja) 薬剤及びその製造方法
US20140024633A1 (en) Orally administrable gallium compositions and methods of use
CN1265560A (zh) 治疗糖尿病的组成物与方法
CN103237543A (zh) 含有镧化合物的胶囊和粉末制剂
CN1819820A (zh) 包含左甲状腺素钠的药物制剂
US20170172960A1 (en) Pharmaceutical formulations for treating kidney stones and methods for fabricating and using thereof
CN1108150C (zh) 增加钙摄取的方法及所用的制剂
WO2021257806A1 (en) Iodide for treatment of nonthyroidal illness syndrome
CN102961340B (zh) 纳米级胰岛素及其制备方法
JP4293757B2 (ja) メチルメチオニンスルホニウムクロライド含有製剤の製造方法
MXPA00003219A (en) Pharmaceutical compositions for oral administration of molecular iodine
US20210252047A1 (en) Use of halogen compounds for the treatment and prevention of tissue injury and post-intensive care syndrome
US20140193525A1 (en) Methods for treating or preventing radiocontrast agent induced kidney injury
JPH02207A (ja) 塩酸ブロムヘキシン含有製剤
WO2003103689A1 (en) Molecular iodine pharmaceutical composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20040526

Termination date: 20091127